Article 04 Aug 2025 Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques Canada IP
Article 31 Jul 2025 Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime Canada IP
Article 20 Jun 2025 Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials Canada Healthcare
Article 23 Dec 2024 Novel Biosimilar Anti-Trust Complaint Involving Janssen's STELARA (Ustekinumab) Dismissed By The Canadian Competition Tribunal Canada Anti-trust
Article 23 Dec 2024 Federal Court Of Appeal: No Single Or Mandatory Approach To Obviousness; Prior Art Disclosing Multiple Options Can Anticipate Canada IP
Article 19 Dec 2024 Federal Court Of Appeal: Patented Medicine Prices Review Board "Crashed" Through "Guardrails" In Attempt To Regulate Unpatented Medicine Canada IP
Article 29 Aug 2024 JAMP Launches Novel Competition Complaint Alleging Janssen Abused Its Dominance Over Stelara (Ustekinumab) Canada IP
Article 25 Jun 2021 Federal Court Of Appeal Affirms: Summary Adjudication Of Patent Disputes Is Viable In Canada Canada IP
Article 16 Mar 2021 Ontario Court Dismisses Apotex Patent Damages Case Grounded In 400 Year Old Statute Of Monopolies Canada IP
Article 06 Nov 2020 2020 Brings Growing Trend Of Patent Cases Decided By Way Of Summary Trial Canada IP
Article 03 Jun 2020 Tactical Use Of Threatening Cease And Desist Letters Discouraged By The Court Canada IP
Article 18 May 2020 Canadian Federal Court's Notice Of Experimental Testing Is Inapplicable To Testing Conducted Prior To Litigation Canada Litigation
Article 05 May 2020 First Trial Decision Under Canada's Amended Patented Medicines (Notice Of Compliance) Regulations Offers Guidance On Key Issues Canada IP